These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35281839)

  • 1. Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer.
    Cao L; Li T; Ba Y; Chen E; Yang J; Zhang H
    Front Genet; 2022; 13():801484. PubMed ID: 35281839
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer.
    Cao L; Ba Y; Yang J; Zhang H
    Aging (Albany NY); 2022 Jun; 14(12):5131-5152. PubMed ID: 35748788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of bacterial lipopolysaccharide-related genes signature based on T cells for predicting prognosis in colorectal cancer.
    Cao L; Ba Y; Chen F; Zhang S; Zhang H
    Aging (Albany NY); 2024 Aug; 16(15):11606-11625. PubMed ID: 39115879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 6. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
    Zhang C; Zhao Z; Liu H; Yao S; Zhao D
    Front Genet; 2021; 12():657658. PubMed ID: 34322151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer.
    Zhuang Z; Cai H; Lin H; Guan B; Wu Y; Zhang Y; Liu X; Zhuang J; Guan G
    J Oncol; 2021; 2021():5818512. PubMed ID: 34840571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of m6A-related lncRNAs as prognostic signature within colon tumor immune microenvironment.
    Cao L; Zhang S; Ba Y; Zhang H
    Cancer Rep (Hoboken); 2023 Jun; 6(6):e1828. PubMed ID: 37178411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
    Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
    Front Genet; 2021; 12():744304. PubMed ID: 34976004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
    Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
    World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
    Liu J; Xu W; Li S; Sun R; Cheng W
    Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
    [No Abstract]   [Full Text] [Related]  

  • 15. CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma.
    Li Z; Feng Y; Li P; Wang S; Liu X; Xia S
    Int J Gen Med; 2022; 15():3809-3826. PubMed ID: 35418778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of a colon cancer prognostic model based on tumor mutation burden-related genes.
    Zou D; Xu T
    Sci Rep; 2024 Feb; 14(1):2867. PubMed ID: 38311637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
    Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G
    EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the Role of Oxidative Stress-Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer.
    Liu Q; Yang X; Yin Y; Zhang H; Yin F; Guo P; Zhang X; Sun C; Li S; Han Y; Yang Z
    Oxid Med Cell Longev; 2022; 2022():6575534. PubMed ID: 36561981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer.
    Liu D; Xu Y; Fang Y; Hu K
    Front Genet; 2022; 13():885553. PubMed ID: 35692814
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
    Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
    Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.